-

DNA Data Storage Alliance Publishes First White Paper, Launches Website

-- New Storage Technologies Needed to Address Emerging Data Oceans --

-- Dense, Stable, Low Power Data Storage in DNA Provides Option to Traditional Storage --

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--The DNA Data Storage Alliance, an organization of more than 25 leading companies formed by Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) together with Microsoft Research, today announced its first white paper titled “Preserving our Digital Legacy: An Introduction to DNA Data Storage.”

The white paper, which can be found on the newly launched DNA Data Storage Alliance website, www.dnastoragealliance.org, presents DNA data storage fundamentals in an accessible way for both technically curious readers and for IT business, computer science or electrical engineering readers interested in the benefits, a technical overview, and the cost of ownership of this potential new storage medium. It discusses why DNA data storage is needed and expected to address the exponential growth of digital data.

A recent Gartner reporti estimates that “In 2020, humans likely generated in excess of 400 ZB of digital ‘stuff’ – equivalent to 400 million petabytes or 400 billion terabytes (or 40 ‘shoeboxes’ of DNA data storage).” Further, “Gartner considers a 35% per-year growth scenario – closely reflecting the actual growth we saw beginning in 2010, a year that might be considered the birth of the cloud storage area – to be most likely.” According to the report, “new breeds of storage technologies must be created in response to the emerging need for immense available capacity at minimal cost in enterprise data centers.”

The density of DNA data storage is unprecedented. If the space inside an LTO cassette (approximately 235,000 mm3) were filled with DNA-based bits, the cassette could hold about 2,000,000 TB, or about 115,000 times the number of bits on an LTO-9 tape. In addition, encapsulated DNA has been shown to remain stable for 1000’s of years, even in harsh conditions.

“It’s undeniable that data growth is outpacing the scalability of today’s storage solutions. Literally, everything we do revolves around data – and capturing, storing, processing and mining it only serves to create even more data. The density and stability of DNA storage will help the industry cost-effectively cope with the expected future growth of archival data for many decades to come,” said Steffen Hellmold, vice president, corporate strategic initiatives, Western Digital.

Another key aspect of DNA as a storage medium is the immutability of its format. With existing storage technologies, the physical structure and format of the media and the methods used to read and write to it are fundamentally coupled. In contrast, DNA’s structure means that any generation of DNA readers and writers will be able to read and write DNA as long as the bit encoding formats are saved.

“The method for reading back data – either periodically to check data quality, or when needed for processing – is critically important in the life sciences as well as for data storage. Due to DNA’s universal format, DNA media will always be readable and writable,” stated Alex Aravanis, M.D., Ph.D., chief technology officer at Illumina. “We continue to drive sequencing technology forward at a rapid rate, with new applications like DNA data storage, and anticipate an active role in this market.”

“In addition to density, stability and eternal relevance, DNA data storage provides a far more sustainable option, requiring negligible space and energy when compared to current data centers that use an ever-growing amount of power and land,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “Taken together, DNA’s storage density, durability and minimal maintenance costs radically reduce the cost of maintaining digital data in DNA over time, making it a viable option for long-term archival data retention.”

“The intersection of the trend toward massive digital data storage needs with our ability to manipulate synthetic DNA offers a vision of data archival ability that could radically change the scale of what we store and how long we store it,” commented Karin Strauss, senior principal research manager at Microsoft Research. “Preserving our digital legacy in turn opens possibilities to extract, and even create or discover, new knowledge.”

The DNA Data Storage Alliance expects to release additional white papers detailing use cases and market opportunities and requirements. If you wish to get involved or just get more information, please visit our web site, www.dnastoragealliance.org, or contact the Alliance at info@dnastoragealliance.org.

About the DNA Data Storage Alliance

The DNA Data Storage Alliance was formed in October 2020 by Illumina, Microsoft Research, Twist Bioscience and Western Digital. Our mission is to create and promote an interoperable storage ecosystem based on manufactured DNA as a data storage medium. Our initial aim is to educate the public and raise awareness about this emerging technology. In addition, as the methods and tools for commercially viable DNA data storage become better understood and more widely available, the Alliance will consider the creation of specifications and standards (e.g., encoding, physical interfaces, retention, file systems) to promote the emergence of interoperable DNA data storage-based solutions that complement existing storage hierarchies. The Alliance neither certifies nor endorses specific products or applications. Follow the Alliance on Twitter and LinkedIn.

i Gartner, ‘Emerging Technologies: New Active/Accessible and Deep Archive Data Requirements – DNA Data Storage’, John Monroe, April 23, 2021

Contacts

Twist Bioscience:
Angela Bitting
925- 202-6211
abitting@twistbioscience.com

Illumina:
Dr. Karen Birmingham
1-646-355-2111
kbirmingham@illumina.com

Western Digital
Media Contact:
Erin Hartin
1-303-601-8035
Erin.Hartin@wdc.com

Investor Contact:
T. Peter Andrew
+1-949-672-9655
peter.andrew@wdc.com
investor@wdc.com

Twist Bioscience Corporation LogoTwist Bioscience Corporation Logo

Twist Bioscience Corporation

NASDAQ:TWST

Release Versions

Contacts

Twist Bioscience:
Angela Bitting
925- 202-6211
abitting@twistbioscience.com

Illumina:
Dr. Karen Birmingham
1-646-355-2111
kbirmingham@illumina.com

Western Digital
Media Contact:
Erin Hartin
1-303-601-8035
Erin.Hartin@wdc.com

Investor Contact:
T. Peter Andrew
+1-949-672-9655
peter.andrew@wdc.com
investor@wdc.com

Social Media Profiles
More News From Twist Bioscience Corporation

Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to support the advancement of pharmaceutical and biotech customers’ pre-clinical studies. “Our new plasmid preps combine the quality and consistency needed for preclinical research with the speed and cost efficiency customers have come to expect from Twist,” said Emily M. Leproust, CEO and co-founder of Tw...

Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025 ended September 30, 2025. Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal fourth quarter and full year 2025 earnings report and the investor presentatio...

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will participate in a fireside chat at the at 7th Annual Wolfe Research Healthcare Conference on Monday, November 17, 2025 at 3:20 pm Eastern Time in New York City. The fireside chat will be webcast live and can be accessed by visiting the “Inves...
Back to Newsroom